This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

FODMAP diet

Authoring team

The acronym FODMAPs (which stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) was developed to describe these poorly absorbed, short-chain carbohydrates

FODMAPs are poorly absorbed in the small intestine and reach the colon undigested

  • cause an osmotic increase of water content in the intestines and increased gas production due to bacterial fermentation (1,2)
  • occurs both in healthy person and in patients with IBS, where it is thought to cause symptoms due to visceral hypersensitivity and altered motility (2,3)

A treatment course of the low FODMAP diet commences with an elimination period of 4-8 weeks, excluding or restricting foods high in FODMAPs

  • when symptom relief is reported, foods high in FODMAPs are reintroduced one by one to identify the type and amount of FODMAPs, which can be tolerated

Patient information on the FODMAP diet

Reference:

  • Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874-882
  • Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:707-717.
  • Barbara G, Cremon C, De Giorgio R, et al. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.